[1]Murdock,K.C.;Lee,VingJ.;Citarella,RonaldV.;Durr,FrederickE.;Nicolau,Gabriela;Kohlbrenner,Michael[JournalofMedicinalChemistry,1993,vol.36,#15,p.2098-2101]
[1]Murdock,K.C.;Lee,VingJ.;Citarella,RonaldV.;Durr,FrederickE.;Nicolau,Gabriela;Kohlbrenner,Michael[JournalofMedicinalChemistry,1993,vol.36,#15,p.2098-2101]
78186-34-2
[1]Murdock,K.C.;Lee,VingJ.;Citarella,RonaldV.;Durr,FrederickE.;Nicolau,Gabriela;Kohlbrenner,Michael[JournalofMedicinalChemistry,1993,vol.36,#15,p.2098-2101]
[1]Murdock,K.C.;Lee,VingJ.;Citarella,RonaldV.;Durr,FrederickE.;Nicolau,Gabriela;Kohlbrenner,Michael[JournalofMedicinalChemistry,1993,vol.36,#15,p.2098-2101]
[1]Murdock;Child;Lin;Warren;Fabio;Lee;Izzo;LangJr.;Angier;Citarella;Wallace;Durr[JournalofMedicinalChemistry,1982,vol.25,#5,p.505-518]
Title: In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
Journal: Bioorganic & medicinal chemistry letters 20101215
Title: Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
Journal: Biochemical pharmacology 20100615
Title: meso-Substituted bisanthenes as soluble and stable near-infrared dyes.
Journal: The Journal of organic chemistry 20100205
Title: Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism.
Journal: Chemical research in toxicology 20080401
Title: Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
Journal: The Journal of pharmacy and pharmacology 20080201
Title: In silico identification and biochemical characterization of novel inhibitors of NQO1.
Journal: Bioorganic & medicinal chemistry letters 20061215
Title: Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Journal: Cancer research 20030315
Title: A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Journal: Investigational new drugs 19850101
Title: Sissi C, et al. DNA-binding preferences of Bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoning. Mol Pharmacol. 1998 Dec;54(6):1036-45.
Title: Yap HY, et al. Bisantrene, an active new drug in the treatment of metastatic breast cancer. Cancer Res. 1983 Mar;43(3):1402-4.
